• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations.《2022 年健康经济评估报告标准(CHEERS 2022)声明:健康经济评估报告更新指南》
Appl Health Econ Health Policy. 2022 Mar;20(2):213-221. doi: 10.1007/s40258-021-00704-x. Epub 2022 Jan 11.
2
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations.《2022 年健康经济评估报告标准》(CHEERS 2022)声明:健康经济评估报告的更新指南。
Pharmacoeconomics. 2022 Jun;40(6):601-609. doi: 10.1007/s40273-021-01112-8. Epub 2022 Jan 11.
3
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations.2022 年健康经济评估报告标准(CHEERS 2022)声明:健康经济评估报告的更新指南。
BMC Public Health. 2022 Jan 27;22(1):179. doi: 10.1186/s12889-021-12491-0.
4
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations.2022 年健康经济评估报告标准(CHEERS 2022)声明:健康经济评估报告的更新指南。
J Manag Care Spec Pharm. 2022 Feb;28(2):146-155. doi: 10.18553/jmcp.2022.28.2.146.
5
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations.2022 年健康经济评估报告标准(CHEERS 2022)声明:健康经济评估报告的更新指南。
BMC Med. 2022 Jan 12;20(1):23. doi: 10.1186/s12916-021-02204-0.
6
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations.2022 年健康经济评估报告标准(CHEERS 2022)声明:健康经济评估报告的更新指南。
BMC Health Serv Res. 2022 Jan 27;22(1):114. doi: 10.1186/s12913-021-07460-7.
7
Consolidated health economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations.2022 年健康经济评估报告标准(CHEERS 2022)声明:健康经济评估报告的更新指南。
Int J Technol Assess Health Care. 2022 Jan 11;38(1):e13. doi: 10.1017/S0266462321001732.
8
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations.《2022年卫生经济评估报告合并标准》(CHEERS 2022)声明:卫生经济评估的更新报告指南。
Clin Ther. 2022 Feb;44(2):158-168. doi: 10.1016/j.clinthera.2022.01.011. Epub 2022 Feb 12.
9
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations.《2022 年健康经济评估报告标准》(CHEERS 2022)声明:健康经济评估报告的更新指南。
Value Health. 2022 Jan;25(1):3-9. doi: 10.1016/j.jval.2021.11.1351.
10
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations.2022 年健康经济评估报告标准(CHEERS 2022)声明:健康经济评估报告的更新指南。
BJOG. 2022 Feb;129(3):336-344. doi: 10.1111/1471-0528.17012.

引用本文的文献

1
Clinical and cost-effectiveness of percutaneous nephrolithotomy, flexible ureterorenoscopy and extracorporeal shockwave lithotripsy for lower pole stones: the PUrE RCTs.经皮肾镜取石术、软性输尿管肾镜检查和体外冲击波碎石术治疗下极结石的临床疗效及成本效益:PUrE随机对照试验
Health Technol Assess. 2025 Aug;29(40):1-186. doi: 10.3310/WFRE6844.
2
Type 2 Diabetes and Financial Outcomes.2型糖尿病与财务状况
JAMA Netw Open. 2025 Jul 1;8(7):e2523453. doi: 10.1001/jamanetworkopen.2025.23453.
3
Early health economic analysis of virtual reality therapy for pain management after surgery.虚拟现实疗法用于术后疼痛管理的早期卫生经济学分析。
Int J Surg. 2025 Jun 1;111(6):3798-3809. doi: 10.1097/JS9.0000000000002385. Epub 2025 May 16.
4
Transarterial radioembolization vs transarterial chemoembolization with drug-eluting beads for treating hepatocellular carcinoma: a cost-effectiveness analysis in Japanese healthcare system.经动脉放射性栓塞与载药微球经动脉化疗栓塞治疗肝细胞癌的成本效果分析:日本医疗体系视角。
Jpn J Radiol. 2024 Dec;42(12):1501-1515. doi: 10.1007/s11604-024-01640-1. Epub 2024 Sep 26.
5
Cost-effectiveness analysis of segmental adrenal venous sampling with radiofrequency ablation for primary aldosteronism in Japan.日本原发性醛固酮增多症射频消融术分段肾上腺静脉采血的成本效益分析。
Jpn J Radiol. 2025 Feb;43(2):290-300. doi: 10.1007/s11604-024-01665-6. Epub 2024 Sep 25.
6
Laparoscopic cholecystectomy versus conservative management for adults with uncomplicated symptomatic gallstones: the C-GALL RCT.腹腔镜胆囊切除术与保守治疗成人单纯症状性胆囊结石的比较:C-GALL RCT。
Health Technol Assess. 2024 Jun;28(26):1-151. doi: 10.3310/MNBY3104.
7
Integration of primary contact physiotherapists in the emergency department for individuals presenting with minor musculoskeletal disorders: Protocol for an economic evaluation.将初级接触物理治疗师整合到急诊部门,用于治疗出现轻微肌肉骨骼疾病的个体:一项经济评价的方案。
PLoS One. 2023 Sep 14;18(9):e0277369. doi: 10.1371/journal.pone.0277369. eCollection 2023.
8
Vaccinating women previously treated for human papillomavirus-related cervical precancerous lesions is highly cost-effective in China.在中国,为曾因人乳头瘤病毒相关宫颈前病变而接受治疗的女性接种疫苗具有很高的成本效益。
Front Immunol. 2023 Mar 27;14:1119566. doi: 10.3389/fimmu.2023.1119566. eCollection 2023.
9
Global trends in the health economics field of PD-1/PD-L1 inhibitors: A bibliometric and visualized study.PD-1/PD-L1抑制剂健康经济学领域的全球趋势:一项文献计量与可视化研究
Front Pharmacol. 2023 Mar 22;14:1141075. doi: 10.3389/fphar.2023.1141075. eCollection 2023.
10
Simulation models of sugary drink policies: A scoping review.含糖饮料政策模拟模型:范围综述。
PLoS One. 2022 Oct 3;17(10):e0275270. doi: 10.1371/journal.pone.0275270. eCollection 2022.

本文引用的文献

1
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force.《健康经济评估报告标准(CHEERS)》2022 年解释与详述:ISPOR CHEERS II 良好实践工作组报告。
Value Health. 2022 Jan;25(1):10-31. doi: 10.1016/j.jval.2021.10.008.
2
Patient and Public Involvement in Health Economics and Outcomes Research.患者及公众参与卫生经济学与结果研究。
Patient. 2021 Jul;14(4):379-380. doi: 10.1007/s40271-021-00505-3. Epub 2021 Mar 17.
3
Distributional Cost-Effectiveness Analysis Comes of Age.分布成本效益分析走向成熟。
Value Health. 2021 Jan;24(1):118-120. doi: 10.1016/j.jval.2020.10.001. Epub 2020 Nov 7.
4
Involving Patients in Health Economics Research: "The PACTS Principles".让患者参与健康经济学研究:“PACTS 原则”。
Patient. 2021 Jul;14(4):429-434. doi: 10.1007/s40271-020-00461-4. Epub 2020 Oct 12.
5
Making health economic models Shiny: A tutorial.让健康经济模型变得出色:教程
Wellcome Open Res. 2020 Jul 31;5:69. doi: 10.12688/wellcomeopenres.15807.2. eCollection 2020.
6
Principles for deliberative processes in health technology assessment.卫生技术评估中的审议程序原则。
Int J Technol Assess Health Care. 2020 Aug 4:1-8. doi: 10.1017/S0266462320000550.
7
Growth and capacity for cost-effectiveness analysis in Africa.非洲的增长和成本效益分析能力。
Health Econ. 2020 Aug;29(8):945-954. doi: 10.1002/hec.4029. Epub 2020 May 15.
8
Criteria and Process for Initiating and Developing an ISPOR Good Practices Task Force Report.启动和制定 ISPOR 良好实践工作组报告的标准和流程。
Value Health. 2020 Apr;23(4):409-415. doi: 10.1016/j.jval.2020.03.001.
9
Reporting guidelines of health research studies are frequently used inappropriately.健康研究报告指南经常被不恰当地使用。
J Clin Epidemiol. 2020 Jun;122:87-94. doi: 10.1016/j.jclinepi.2020.03.006. Epub 2020 Mar 14.
10
Reproducible research practices, openness and transparency in health economic evaluations: study protocol for a cross-sectional comparative analysis.可重复性研究实践、健康经济评估中的开放性和透明度:一项横断面比较分析的研究方案。
BMJ Open. 2020 Feb 13;10(2):e034463. doi: 10.1136/bmjopen-2019-034463.

《2022 年健康经济评估报告标准(CHEERS 2022)声明:健康经济评估报告更新指南》

Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations.

机构信息

School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada.

Institute of Health Economics, Edmonton, AL, Canada.

出版信息

Appl Health Econ Health Policy. 2022 Mar;20(2):213-221. doi: 10.1007/s40258-021-00704-x. Epub 2022 Jan 11.

DOI:10.1007/s40258-021-00704-x
PMID:35015207
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8847248/
Abstract

Health economic evaluations are comparative analyses of alternative courses of action in terms of their costs and consequences. The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement, published in 2013, was created to ensure health economic evaluations are identifiable, interpretable, and useful for decision making. It was intended as guidance to help authors report accurately which health interventions were being compared and in what context, how the evaluation was undertaken, what the findings were, and other details that may aid readers and reviewers in interpretation and use of the study. The new CHEERS 2022 statement replaces previous CHEERS reporting guidance. It reflects the need for guidance that can be more easily applied to all types of health economic evaluation, new methods and developments in the field, as well as the increased role of stakeholder involvement including patients and the public. It is also broadly applicable to any form of intervention intended to improve the health of individuals or the population, whether simple or complex, and without regard to context (such as health care, public health, education, social care, etc). This summary article presents the new CHEERS 2022 28-item checklist and recommendations for each item. The CHEERS 2022 statement is primarily intended for researchers reporting economic evaluations for peer reviewed journals as well as the peer reviewers and editors assessing them for publication. However, we anticipate familiarity with reporting requirements will be useful for analysts when planning studies. It may also be useful for health technology assessment bodies seeking guidance on reporting, as there is an increasing emphasis on transparency in decision making.

摘要

健康经济评估是对不同行动方案的成本和结果进行的比较分析。2013 年发布的《健康经济评估报告标准(CHEERS)》声明旨在确保健康经济评估能够被识别、解释和用于决策。它旨在为作者提供指导,准确报告正在比较的健康干预措施及其所处的背景、评估的开展方式、结果如何以及其他可能有助于读者和评论员解释和使用研究的详细信息。新的 CHEERS 2022 声明取代了以前的 CHEERS 报告指南。它反映了需要一种更易于应用于所有类型的健康经济评估、该领域的新方法和新发展以及利益相关者(包括患者和公众)参与程度增加的指导。它也广泛适用于任何旨在改善个人或人群健康的干预措施,无论其简单或复杂,且不考虑其所处的环境(如医疗保健、公共卫生、教育、社会关怀等)。这篇总结文章介绍了新的 CHEERS 2022 清单和 28 项建议。CHEERS 2022 声明主要针对为同行评审期刊报告经济评估的研究人员以及为发表文章对其进行评估的同行评审员和编辑。然而,我们预计熟悉报告要求对计划研究的分析师会很有用。它也可能对寻求报告指导的医疗技术评估机构有用,因为决策的透明度越来越受到重视。